New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Apyx Medical Corporation
APYX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

41M

Medical - Devices

Next Earning date - 14 Nov 2024

41M

Medical - Devices

Next Earning date - 14 Nov 2024

1.18USD
Shape-0.01 ( -0.54%)
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-67%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated October 20, 2024
1W 1.72 % 1M 0.85 % 3M -15.11 % 1Y -49.57 %

Key Metrics

Shape
  • Market Cap

    41.00M


  • Shares Outstanding

    34.64M


  • Share in Float

    29.04M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1.1836


  • Average Volume

    37498


  • Beta

    1.202


  • Range

    0.967-3.26


  • Industry

    Medical - Devices


  • Website

    https://www.apyxmedical.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.72x

P/S Ratio

2.78x

P/B Ratio

2.3

Debt/Equity

-49.5%

Net Margin

$-0.8

EPS

How APYX compares to sector?

P/E Ratio

Relative Strength

Shape

APYX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$54M

Shape346%

2025-Revenue

$0.67

Shape-251%

2025-EPS

$28M

Shape-421%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

BTIG

initialise

Previous: Not converted

2024-10-16

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.17
vs -0.12

Q4.22

arrow
arrow

N/A

-0.17
vs -0.06

Q1.23

arrow
arrow

N/A

-0.10
vs -0.17

Q2.23

arrow
arrow

N/A

-0.11
vs -0.16

Q3.23

arrow
arrow

N/A

-0.13
vs -0.17

Q4.23

arrow
arrow

N/A

-0.19
vs -0.17

Q1.24

arrow
arrow

N/A

-0.22
vs -0.10

Q2.24

arrow
arrow

N/A

-0.19
vs -0.11

Q3.24

arrow
arrow

N/A

-0.18
vs -0.13

Q4.24

arrow
arrow

N/A

-0.11
vs -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-23%

9.1M  vs 11.8M

Q4.22

arrow
arrow

-25%

12.6M  vs 16.8M

Q1.23

arrow
arrow

-3%

12.1M  vs 12.5M

Q2.23

arrow
arrow

+32%

13.6M  vs 10.3M

Q3.23

arrow
arrow

+75%

16M  vs 9.1M

Q4.23

arrow
arrow

+16%

14.7M  vs 12.6M

Q1.24

arrow
arrow

+20%

14.5M  vs 12.1M

Q2.24

arrow
arrow

-10%

12.1M  vs 13.6M

Q3.24

arrow
arrow

-29%

11.4M  vs 16M

Q4.24

arrow
arrow

+16%

17M  vs 14.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-14%

-0.14
vs -0.12

Q4.22

arrow
arrow

-16%

-0.16
vs -0.14

Q1.23

arrow
arrow

-10%

-0.10
vs -0.16

Q2.23

arrow
arrow

-3%

-0.03
vs -0.10

Q3.23

arrow
arrow

-14%

-0.14
vs -0.03

Q4.23

arrow
arrow

-36%

-0.36
vs -0.14

Q1.24

arrow
arrow

-37%

-0.37
vs -0.36

Q2.24

arrow
arrow

-44%

-0.44
vs -0.37

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

55

55
vs 66

-17%

Q4.22

arrow
arrow

52

52
vs 55

-5%

Q1.23

arrow
arrow

57

57
vs 52

10%

Q2.23

arrow
arrow

60

60
vs 57

5%

Q3.23

arrow
arrow

64

64
vs 60

7%

Q4.23

arrow
arrow

63

63
vs 64

-2%

Q1.24

arrow
arrow

54

54
vs 63

-14%

Q2.24

arrow
arrow

52

52
vs 54

-4%

Earnings Growth

Latest News